Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction...

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• ATP-binding cassette transporter A1 (ABCA1) facilitates cholesterol efflux to apolipoprotein A-I (apoA-I), crucial for HDL synthesis and cardiovascular protection.
• The apoA-I/ABCA1 interaction activates Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3), reducing pro-inflammatory cytokine expression in macrophages.

Purpose of the Study:

• To elucidate the distinct mechanisms by which the apoA-I/ABCA1 interaction suppresses inflammation.
• To investigate the roles of cholesterol efflux and STAT3 activation in the anti-inflammatory effects of the apoA-I/ABCA1 pathway.

Main Methods:

• Utilized specific ABCA1 mutants with isolated cholesterol efflux or STAT3-activating capacities.
• Assessed the impact of these mutants on pro-inflammatory cytokine expression in macrophages.
• Investigated the involvement of suppressor of cytokine signaling 3 (SOCS3) in the anti-inflammatory pathway.

Main Results:

• apoA-I/ABCA1 interaction-induced STAT3 activation, independent of cholesterol efflux, significantly reduced pro-inflammatory cytokine expression.
• The anti-inflammatory effect mediated by the apoA-I/ABCA1/STAT3 pathway is dependent on SOCS3.
• Cholesterol efflux mediated by apoA-I/ABCA1, without STAT3 activation, also decreased pro-inflammatory cytokine expression.

Conclusions:

• The apoA-I/ABCA1 interaction employs dual pathways to suppress inflammation: cholesterol efflux and STAT3 activation.
• These two branches synergistically reduce pro-inflammatory cytokine expression in macrophages, highlighting a complex anti-inflammatory mechanism.